Faculty

Symposium organizers

Symposium faculty

Faculty biographies

Rupesh Agrawal, MD, MMed, FRCS, FAMS, MBBS

Dr. Agrawal practises as a consultant ophthalmologist at the National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.

After completing his medical studies at Nagpur, he did postgraduate studies and a fellowship in uveitis and ocular trauma at Sankara Netralaya, Chennai. He then worked as a consultant ophthalmologist (uveitis, ocular trauma and cataract) at Shri Ganapati Netralaya, Jalna. He also worked briefly at LV Prasad Eye Institute before moving to Singapore in 2009. There, he has been involved in significant translational and basic science research projects. He recently completed an overseas research training fellowship, awarded by the National Medical Research Council, Ministry of Health, Singapore, at University College London on retinal imaging using retinal leukogram and erythrogram projects. He also worked on mechanical properties of the red blood cell and its implications in microvascular disorders. As a visiting scholar, he also had an opportunity to work with Professor Carlos Pavesio and accomplished numerous research projects at the prestigious Moorfields Eye Hospital, London, UK. He has also done global scholars' research training at Harvard Medical School.

Dr. Agrawal's areas of interest are ocular inflammatory disorders including cytokines, ocular tuberculosis and HIV, complex cataract, ocular trauma, ocular nanotechnology, blood corpuscular abnormalities in context of microvascular disorders and retinal imaging. He is also looking at a "choroidal vascularity index" based on choroidal imaging using optical coherence tomography.

Dr. Agrawal has published extensively on ocular inflammation and ocular trauma in peer-reviewed journals and has presented numerous free papers and delivered lectures on ocular trauma and uveitis both nationally and internationally. He is actively involved in numerous collaborative projects on uveitis. He is the recipient of many grants for numerous basic science projects pertinent to ocular inflammation.

He is currently secretary of the International Society of Ocular Trauma. He has received many awards and research grants. In 2011, the president of Singapore bestowed Dr. Agrawal with the Healthcare Humanity Award for his humanitarian and pro bono projects in remote areas of the world. He established a not-for-profit organization in Singapore, VIRAJ Healthcare Foundation, to promote quality health care in the community. He also serves as a senior board member of the charitable organization, the Vision Mission, and is heavily involved in other charity projects across Asia.

Financial disclosure: I do not have any affiliation (financial or otherwise) with a commercial organization.

Iqbal (Ike) Ahmed, MD, FRCSC

Dr. Ahmed is a fellowship-trained glaucoma, cataract, and anterior segment surgeon with a practice focus on the surgical management of glaucoma, complex cataract and intraocular lens complications. He is board certified in ophthalmology in Canada and the USA, and is an active member of numerous national and international societies.

Dr. Ahmed has become world renowned for his skills and groundbreaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications. He is recognized as being one of the most experienced complex eye surgeons in the world and has trained numerous surgeons in innovative surgical techniques. Furthermore, he has been at the leading edge of novel treatments for glaucoma, cataract and lens implant surgery. Patients are referred to him locally, nationally, and from around the world. He has been invited to perform surgery on four continents across the globe. In 2010, Dr. Ahmed was selected as one of Canada's "Top 40 under 40" - a prestigious national award recognizing significant achievements at a young age. In 2014, Dr. Ahmed was selected to receive the prestigious Binkhorst medal at ASCRS, which has been awarded to the world's most prominent ophthalmologists whose careers have made significant contributions to the science and practice of ophthalmology.

Dr. Ahmed has a keen interest in the development of advanced microsurgical devices and techniques in glaucoma surgery and complicated cataract extraction, and is actively involved in research and medical education at a national and international level. He has received research grants to study glaucoma medications, glaucoma laser and surgical devices/techniques, angle closure glaucoma, anterior segment and retinal/optic nerve imaging in glaucoma, cataract surgical techniques and devices, and intraocular lens designs. Dr. Ahmed has designed innovative glaucoma diamond scalpels for surgery, microsurgical instrumentation, and devices, implants, and techniques for the management of the dislocated cataract, iris reconstruction, and glaucoma implant devices. He has done pioneering work in innovative glaucoma surgery, developing and coining the term "Micro-Invasive Glaucoma Surgery (MIGS)" as a new genre of surgical approaches and devices. He also performed the first laser cataract surgery in Canada. As a result of his innovative expertise, Dr. Ahmed has been asked to consult for a variety of companies and manufacturers, especially pertaining to the development of new devices and technologies.

He founded and directs the Toronto Cataract Course and the COS Surgical Teaching Series, as well as a number of AAO and ASCRS Courses. He directed the third International Congress on Glaucoma Surgery in May 2006 in Toronto. He sits on the editorial boards of Ophthalmology, Canadian Journal of Ophthalmology, Ocular Surgery News, Cataract and Refractive Surgery Today, and Glaucoma Today, and is a reviewer for numerous journals.

Dr. Ahmed has published over 100 peer-reviewed papers, as well as numerous book chapters, and has won five film festival awards, six best papers of the session, and a poster award at ASCRCS, as well as an ESCRS first place video award and AAO "Best of Show" award. He has given over 750 scientific presentations thus far in his career, including 31 visiting professor's lectures around the world.

He is currently an assistant professor at the University of Toronto, and a clinical professor at the University of Utah. He is the Director of the Glaucoma and Advanced Anterior Segment Surgery (GAASS) fellowship at the University of Toronto, and Director of Research at the Kensington Eye Institute, University of Toronto. He has trained glaucoma specialists who are now practicing in Canada and around the world, as well as residents and medical students. Dr. Ahmed has a large tertiary glaucoma/cataract practice at Prism Eye Institute in the Greater Toronto Area, and primarily performs surgery at the Trillium Health Partners, Mississauga, Ontario, the Kensington Eye Institute, University of Toronto, and TLC Mississauga.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

Kashif Baig, MBA, MD

Dr. Baig is a cornea, anterior segment, and refractive surgeon providing tertiary level care at the University of Ottawa Eye Institute. He is an assistant professor at the University of Ottawa, pediatric cornea consultant at the Children's Hospital of Eastern Ontario, principal investigator at the Ottawa Hospital Research Institute, and director of clinical and research fellowships in cornea, anterior segment, and refractive surgery. He is also the president of the Canadian Cornea, External Disease, and Refractive Surgery Society.

He completed his medical and residency training at McGill University, Master of Business Administration degree (Health Services Management) at McMaster University, and fellowship training in the United States. He has a strong interest in the development and implementation of surgical innovations in corneal and anterior segment surgery.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Alcon
2. Allergan
3. Bausch and Lomb
4. Concordia Rx
5. Johnson & Johnson Vision
6. Labtician
7. LinCor Biosciences
8. Merck
9. Moria Surgical
10. Santen Canada

Maria H. Berrocal, MD

Dr. Berrocal is Director of Berrocal and Associates in San Juan, Puerto Rico and faculty at the University of Puerto Rico. She received her Medical Degree from the University of Illinois. She completed her ophthalmology training at the University of Puerto Rico where she received the best surgeon award. She completed her surgical and medical retina training at the department of Ophthalmology New York Hospital/Cornell University. She then completed a medical retina fellowship with Dr. J Donald Gass at Bascom Palmer Eye Institute and was a Heed Fellow Awardee.

Her research interests include new techniques in vitreoretinal surgery, with a particular interest in complications of diabetic retinopathy. She has participated in numerous studies of novel treatments for the management of diabetic complications.

She belongs to and has held leadership positions in the Panamerican Vitreoretinal Society, Panamerican Ophthalmological Society, Retina Society, American Society of Retinal Specialists (ASRS), American Academy of Ophthalmology (AAO), and Women in Ophthalmology (WIO). She is past president of the Panamerican Vitreoretinal Society. She is on the editorial board of Retina Today, Argentinian Retinal Journal and Egyptian Ophthalmology.

She has received the American Academy of Ophthalmology Senior Achievement Award, and American Society of Retinal Specialists Senior Honor Award. She received the Vit Buckle Society Surgical Excellence Award. She has received the Doctors Choice Award yearly since 2002 and the Cardinals Award. Dr. Berrocal has been an invited speaker and visiting surgeon in over 20 countries. She has authored and co-authored over 70 articles and book chapters. Dr. Berrocal has held numerous positions in philanthropic societies. She has established educational scholarships for cancer survivors, elementary school children and a drug treatment centre.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Alcon
2. Allergan

Christopher L.B. Canny, MD, FRCSC

Dr. Canny completed his medical degree at the University of Alberta in 1970. An internship at Victoria Hospital in London, Ontario was followed by residency training in ophthalmology at the University of Western Ontario. Dr. Canny completed a 2-year fellowship in diseases and surgery of the retina and vitreous at the Wills Eye Hospital (Thomas Jefferson University) in Philadelphia.

For 22 years he practised full time as a retinal consultant and associate professor of ophthalmology at University Hospital in London, Ontario and was head of the hospital department of ophthalmology for 10 years. His major clinical research interest was diabetic retinopathy taking part in the Diabetic Retinopathy Study (DRS) and the Diabetes Complications Control Trial (DCCT).

Dr. Canny established the division of ophthalmology at Skeikh Khalifa Medical City in Abu Dhabi, UAE in 2000 and was head of the division for 8 of the 10 years before joining the CMPA in 2011.

Marcus Colyer, MD

Dr. Colyer, a native of Corning, NY, is an ophthalmologist and vitreoretinal surgeon in the U.S. Armed Forces. He graduated from the United States Military Academy at West Point. Subsequently, he attended Pennsylvania State University College of Medicine. Upon graduation, he served as a resident at Walter Reed National Military Medical Center from 2004 to 2008, followed by a fellowship in vitreoretinal surgery at Georgetown University and the Retina Group of Washington.

Dr. Colyer then returned to Walter Reed, where he has served as a vitreoretinal surgeon, director of the Triservice Ocular Trauma Skills Laboratory, residency program director, and chair. He has over 30 peer reviewed publications to his credit on the topic of ocular trauma and visual dysfunction following combat injuries. His current interests include developing novel therapies for management of ocular injuries as well as developing enterprise ophthalmic imaging and data strategies for the United States Military Health System.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. US Department of Defence Research
2. Covalent Medical, LLC
3. National Eye Institute Internal Clinical Research Committee

Michael Dollin, MD

Dr. Dollin is currently a Vitreoretinal Surgeon and Assistant Professor at the University of Ottawa Eye Institute. He received his honours bachelor of science degree with high distinction and doctor of medicine degree from the University of Toronto. He completed his internship and residency training in ophthalmology at the University of Ottawa, where he was appointed co-chief resident. During his residency, he was awarded the Department of Ophthalmology Resident Teaching Award, and was twice presented with The Ottawa Hospital Guardian Angel Pin Award. He went on to complete a Retina fellowship at the prestigious Wills Eye Hospital in Philadelphia, where he was awarded the P. Robb McDonald Award for best fellow research paper at the Wills Eye Hospital Annual Alumni Conference two years in a row.

Dr. Dollin is a member of the Royal College of Physicians and Surgeons of Canada, the Canadian Ophthalmological Society, the American Academy of Ophthalmology, the American Society of Retina Specialists, the Association for Research in Vision and Ophthalmology, and the Ontario and Canadian Medical Associations.

Dr. Dollin currently serves as the Eye Institute's principal investigator on several major multicentre clinical trials and has presented his own research at large national and international academic meetings. He has co-authored scientific papers, book chapters, and non-peer reviewed articles. He serves as a reviewer for the journal Retina and the Canadian Journal of Ophthalmology. His primary research interests include Age-related Macular Degeneration and Diabetic Macular Edema. He enjoys being actively involved in research at the University of Ottawa, as well as the teaching of medical students, residents, and Retina fellows.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Alcon
2. Bayer
3. Novartis

Harminder S. Dua, MD

Dr. Dua is chair and professor of ophthalmology at the Queens Medical Centre, University of Nottingham. He was the ninth president of the Royal College of Ophthalmologists UK (2011-14), served as editor-in-chief of the British Journal of Ophthalmology (2007-14), and was president of EuCornea and of EVER. He is currently a member of the international steering committee for the second Dry Eye Workshop (DEWS II), Academia Ophthalmologica Internationalis, and the American Ophthalmological Society. He is also editor-in-chief of the Journal of EuCornea and chairs the advisory committee of the International Council of Ophthalmology.

Among Dr. Dua's awards and accolades are the Times Higher Education Award 2014 for "research project of the year"; the Rotary Foundation Global Alumni Service to Humanity Award (2013); and the Vice-chancellor's Medal (2016). He was listed by the magazine Ophthalmologist among the top 20 most influential individuals in ophthalmology worldwide (2014); and among the top 100 in 2016. He was one of five ophthalmologists in the list of "Britain's Top Doctors" (2010) published by The Times magazine.

Dr. Dua has been endowed with honorary life memberships in four international academic societies. An eponymous lecture, "The Dua Lecture," Birmingham, and a seminar room in the Nottingham postgraduate centre, "The Dua Room" have been named after him.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Allergan
2. Chiesi
3. Croma
4. Dompe
5. Glaxosmithkline
6. NuVision biotherapeutics
7. Santen
8. Shire
9. Thea

Justis P. Ehlers, MD

Dr. Ehlers is the Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research at the Cole Eye Institute of the Cleveland Clinic. He earned his medical degree at the Washington University School of Medicine in St. Louis, Missouri. He completed his ophthalmology residency at the Wills Eye Institute in Philadelphia, Pennsylvania, where he served as Chief Resident. He then held a vitreoretinal surgery fellowship at the Duke Eye Center in Durham, North Carolina as a Heed Fellow and Ronald G. Michels Fellow.

Dr. Ehlers specializes in the diagnosis and management of medical and surgical vitreoretinal disease. Dr. Ehlers is the Director of the Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research. His laboratory focuses on translational intraoperative optical coherence tomography (OCT) technology, image-guided surgery, and advanced image analysis. Dr. Ehlers has received numerous awards including the ASRS Senior Honor Award and AAO Achievement Awards. Dr. Ehlers was recently recognized as one of the Top 40 Ophthalmologist Under 40.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Alcon
2. Alimera
3. Genentech
4. Leica/Bioptigen
5. Regeneron
6. Santen
7. Thrombogenics
8. Zeiss

Steven M. Gilberg, MD, FRCSC

Dr. Gilberg completed his medical degree and ophthalmology residency at the University of Ottawa followed by a two-year fellowship in ophthalmic plastic and reconstructive surgery at the University of Miami at the Bascom Palmer Eye Institute from 1990-92.

In 1992, Dr. Gilberg joined the Department of Ophthalmology, University of Ottawa. He has been the university chair and head of the Department of Ophthalmology at the Ottawa Hospital for the past 9 years.

Dr. Gilberg has trained 14 fellows in ophthalmic plastic and reconstructive surgery and has over 60 publications and 180 presentations to his credit. He has a particular interest in orbitocranial surgery.

Iyad Habil, MD

Dr. Habil is a cornea specialist and a member of the senior clinical management team at the St. John Eye Hospital Jerusalem, which is a referral centre for the occupied Palestinian territories. He is an experienced cataract surgeon, performs corneal and refractive surgery, including lamellar grafts, and frequently undertakes surgical repair of ocular traumatic injuries. He regularly contributes to teaching of resident doctors in the hospital.

Dr. Iyad received his medical degree from the medical faculty of the Russian's People Friendship University in Moscow, and pursued surgical training in ophthalmology at Hadassah University Hospital in Jerusalem. He successfully completed a Fellowship in External Eye Disease and Cornea at Hadassah before joining the staff at St. John's.

Dr. Iyad comes from Gaza, and resides in Jerusalem with his wife and three children. He is fluent in English, Hebrew, Russian, and Arabic.

Financial disclosure: I do not have any affiliation (financial or otherwise) with a commercial organization.

Julia Haller, MD

Dr. Haller is ophthalmologist-in-chief of Wills Eye Hospital in Philadelphia, where she holds the William Tasman, MD, Endowed Chair, and serves as professor and chair of ophthalmology at Thomas Jefferson University.

One of the world's most renowned retina surgeons, Dr. Haller has published over 350 scientific articles and book chapters. She is a graduate of Princeton University, Harvard Medical School, and the Wilmer/Johns Hopkins ophthalmology residency, with fellowships in eye pathology and retina. She held the Katharine Graham and Robert Welch, MD, professorships at Hopkins, is past president of the Retina Society, the America Society of Retina Specialists and the AUPO Board, a past trustee of Princeton and the Bryn Mawr School, and currently serves as a director of Celgene, president of the Women in Medicine Legacy Foundation, a trustee of the College of Physicians of Philadelphia and the Society of Heed Fellows, and on the Council of the American Ophthalmological Society. Her honours include the AAO's Lifetime Achievement Award, the ASRS's Pyron Award, the Macula Society's Gass Medal, ASB's Louis Braille Award, EURETINA's Kressig Award, and the Heed Award. Her research interests are in retinal pharmacology and surgery, innovative therapies, and health care disparities.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. ThromboGenics
2. Spark Therapeutics
3. Merck
4. Janssen
5. KalVista
6. Celgene

Michael S. Ip, MD

Dr. Ip is professor, Department of Ophthalmology at the David Geffen School of Medicine at the University of California - Los Angeles. He is a member of the Doheny Eye Institute and currently serves as the medical director of the Doheny Image Reading Center. Prior to June 2016, Dr. Ip was on faculty at the University of Wisconsin School of Medicine and Public Health in Madison, WI, and was a co-director of the Fundus Photograph Reading Center at the University of Wisconsin. He also served as director of the Retina Service at the William S. Middleton Memorial Veterans Hospital in Madison, WI. Dr. Ip received his medical degree from New York University and completed his internship at Lenox Hill Hospital, both in New York, New York. He completed his residency at the University of Pittsburgh School of Medicine in Pennsylvania followed by a fellowship in vitreoretinal surgery at the New England Eye Center, Tufts University, in Boston, Massachusetts.

Dr. Ip's research focuses on the design and conduct of clinical trials investigating treatments for diabetic retinopathy, AMD, and retinal venous occlusive disease. As co-director of the Fundus Photograph Reading Center, he has assisted with the collection, analysis, and dissemination of important secondary outcomes in numerous industry and NIH-funded ophthalmic clinical trials. As a clinical site investigator, he has served as the principal investigator on over 17 clinical trials. He has also served as the protocol chair for the clinical trial conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema and as the National Principal Investigator for the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study. In 2003, Dr. Ip and colleagues received an award from the NEI to conduct the SCORE Study. In 2013, this group received funding from the NEI to conduct the SCORE2 Study. This avenue of research continues in his role as the medical director of the Doheny Image Reading Center.

Dr. Ip has authored more than 60 peer-reviewed articles, 20 book chapters, and more than 60 abstracts on these topics as well as has given many national and international presentations. Dr. Ip is also a reviewer for the following six journals: Ophthalmic Surgery and Lasers, Investigative Ophthalmology and Visual Science, American Journal of Ophthalmology, Retina, and Ophthalmology. He is a former associate editor for Archives of Ophthalmology. In addition, he serves on a variety of committees in the American Academy of Ophthalmology, including the Ophthalmic Technology Assessment Committee and the Curriculum Development Committee (COMPASS), and is a member of the Food and Drug Administration Panel on Orphan Drug Development. Dr. Ip has been recognized with several honors, including the Senior Achievement Award and the Leadership Development Program Award, both from the American Academy of Ophthalmology.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Boehringer
2. Genentech
3. Ingelheim
4. Omeros
5. Quark
6. Thrombogenics

David Jordan, MD

Dr. Jordan is professor of ophthalmology at the University of Ottawa Eye Institute. He attended University of Toronto Medical School, and pursued ophthalmology at the University of Ottawa. He undertook a fellowship in oculoplastic surgery with Dr. D. Tse and Dr. J. Nerad at the University of Iowa, followed by a fellowship in oculoplastic surgery with Dr. R.L. Anderson at the University of Utah.

He is a member of the American Society of Ophthalmic Plastic/Reconstructive Surgeons, the European Society of Ophthalmic Plastic/Reconstructive Surgeons, the Canadian Society of Oculoplastic Surgeons, and the Orbital Society.

Dr. Jordan has research interests in orbital surgery, soft tissue filler migration, and the "Shelf Syndrome". He has 280 peer reviewed scientific articles in print, 100 additional non-peer reviewed articles, 45 book chapters in print, 1 textbook entitled Surgical Anatomy of the Ocular Adnexa. He has given over 400 presentations locally, nationally and internationally and has trained 15 fellows in oculoplastic surgery to date.

Financial disclosure: I do not have any affiliation (financial or otherwise) with a commercial organization.

Jeffrey A. Nerad, MD, FACS

Dr. Nerad specializes in Ophthalmic Plastic and Reconstructive Surgery. This subspecialty of ophthalmology combines eye surgery and plastic surgery, correcting cosmetic and reconstructive problems of the eyelids and the tissue of the face surrounding the eyes. Dr. Nerad performs a wide variety of operations for drooping eyelids, watery eyes, and eye socket problems, including thyroid eye disease. Dr. Nerad offers medical, laser and surgical correction of cosmetic facial problems, especially upper and lower eyelid blepharoplasty, as well as treatment of facial wrinkling and sagging. He is considered an international expert in treating orbital diseases. Consultations for adults and children are available with or without referral from other physicians and surgeons.

Dr. Nerad joined the Cincinnati Eye Institute in 2009. Prior to his arrival, he held the position of Professor of Ophthalmology & Otolaryngology at the University of Iowa in Iowa City, Iowa for over 20 years. At the University, he was the Director of the Oculoplastic and Orbital Surgery Service where he performed over 1000 surgeries each year. In 2008, he was awarded the Fuerste Professorship of Ophthalmology for his patient care, teaching and research. During his career as a surgeon and educator, Dr. Nerad has trained hundreds of resident and fellow physicians who now practice throughout the world.

Dr. Nerad attended the University of California for undergraduate training. He completed medical school and residency training at Saint Louis University. Dr. Nerad did fellowship training in Moorfields Eye Hospital in London and at the University of Iowa.

Dr. Nerad is Board Certified in Ophthalmology and a Fellow of the American Academy of Ophthalmology. He is a member of the American and European Societies of Oculoplastic and Reconstructive Surgery, the American Academy of Facial Plastic Surgeons, and the prestigious Orbital Society. Dr. Nerad served on the board of directors of the American Society of Ophthalmic Plastic and Reconstructive Surgery for 5 years and was president of the society in 2010. Dr Nerad has been awarded the Honor and Senior Honor Awards from the American Academy of Ophthalmology and been named among the Best Doctors in America for 20 years. Dr. Nerad has published over 100 scientific papers on a wide variety of topics related to eyelid and orbital surgery. He serves on the editorial boards of several professional journals. He has authored and coauthored several textbooks which are among the most widely referred to texts in his area. His latest textbook, Techniques in Ophthalmic Plastic Surgery, was released in 2010. A new edition will be as amiable in 2017. He is a sought after lecturer nationally and has lectured in more than 40 countries across the globe. He is married and the proud father of two daughters.

Financial disclosure: I do not have any affiliation (financial or otherwise) with a commercial organization.

Kirk H. Packo, MD

Dr. Packo has over 32 years' experience as a practising ophthalmologist. He completed his residency training at University of Illinois Eye and Ear Infirmary and his fellowship in Vitreoretinal Surgery at Emory University. He is currently chair and professor, and section director of retina, in the Department of Ophthalmology at Rush University Medical Center. He is also a partner with Illinois Retina Associates and has numerous publications and national/international presentations to his credit.

1. Abbott
2. Alcon
3. Allergan
4. Alimera
5. Covalent Medical & US Retina
6. Genentech
7. Mobius
8. Regeneron

Robert Sergott, MD

Dr. Sergott earned his undergraduate [1971] and medical [1975] degrees from Johns Hopkins University. Following a medical internship at Mary Imogene Bassett Hospital, Cooperstown, NY, he completed an ophthalmology residency at Wills Eye Hospital, Philadelphia, followed by a clinical neuro-ophthalmology fellowship with Joel Glaser at Basom Palmer Eye Institute, Miami, and a multiple sclerosis, neuro-immunology fellowship at the University of Pennsylvania.

Since 1982, he has practised clinical neuro-ophthalmology at Wills Eye Hospital becoming director of the service in 2008. He also is professor of ophthalmology and neurology at Thomas Jefferson University as well as consulting neuro-ophthalmologist for Geisinger Medical Center, Danville, Pennsylvania. In 1996, Ophthalmology Times named him one of the 100 best ophthalmologists in America.

His basic and clinical research activities have included thyroid eye disease, pseudotumour cerebri, non-arteritic ischemic optic neuropathy, giant cell arteritis, multiple sclerosis, trauma to the visual system, and optical coherence tomography. He has authored over 160 articles in peer-reviewed literature.

He also now directs the Optic Nerve Research Center, a knowledge-based reading centre for phase 2, 3, and 4 trials with special emphasis and expertise in neuro-ophthalmic and drug safety applications of OCT.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

1. Biogen
2. Clene Nanomedicine
3. GenSight
4. Heidelberg Engineering
5. Janssen
6. Merck
7. Roche